Ph3 Extension Trial Pembro Adv Tumors

A Multicenter Open-label Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab (MK3475-587)